Progress toward treatments for synaptic defects in autism.

Abstract : Autism spectrum disorder (ASD) encompasses a range of disorders that are characterized by social and communication deficits and repetitive behaviors. For the majority of affected individuals, the cause of ASD remains unknown, but in at least 20% of the cases, a genetic cause can be identified. There is currently no cure for ASD; however, results from mouse models indicate that some forms of the disorder could be alleviated even at the adult stage. Genes involved in ASD seem to converge on common pathways altering synaptic homeostasis. We propose, given the clinical heterogeneity of ASD, that specific 'synaptic clinical trials' should be designed and launched with the aim of establishing whether phenotype 'reversals' could also occur in humans.
Type de document :
Article dans une revue
Nature Medicine, Nature Publishing Group, 2013, 19 (6), pp.685-94. 〈10.1038/nm.3193〉
Liste complète des métadonnées

https://hal-pasteur.archives-ouvertes.fr/pasteur-01470299
Contributeur : Elodie Ey <>
Soumis le : vendredi 17 février 2017 - 11:39:11
Dernière modification le : jeudi 11 janvier 2018 - 06:26:04

Identifiants

Collections

Citation

Richard Delorme, Elodie Ey, Roberto Toro, Marion Leboyer, Christopher Gillberg, et al.. Progress toward treatments for synaptic defects in autism.. Nature Medicine, Nature Publishing Group, 2013, 19 (6), pp.685-94. 〈10.1038/nm.3193〉. 〈pasteur-01470299〉

Partager

Métriques

Consultations de la notice

31